Director-Affiliated Funds Disclose 10.3% Stake, $8M IPO Purchase at Premium

summarizeSummary

Director William Harrington and affiliated investment funds have disclosed a 10.3% beneficial ownership in Mobia Medical, including an $8 million purchase at the IPO price of $15.00, signaling strong confidence post-IPO.

check_boxKey Events

• Significant Beneficial Ownership

  Director William Harrington, through Osage University Partners, now beneficially owns 3,410,899 shares, representing 10.3% of the company's common stock.

• Substantial IPO Investment

  The affiliated funds purchased $8 million worth of common stock at the IPO price of $15.00 per share on May 11, 2026, following the company's recent IPO.

• Premium Purchase Price

  The IPO shares were acquired at $15.00, a notable premium compared to the current stock price of $11.90 and above the 52-week high, indicating strong conviction.

• Post-IPO Lock-Up

  The investment funds are subject to a 180-day lock-up agreement, restricting sales of their shares following the IPO.

auto_awesomeAnalysis

A Schedule 13D filing reveals that Osage University Partners, a group associated with director William Harrington, now beneficially owns 10.3% of Mobia Medical's common stock. This includes an $8 million purchase of shares at the IPO price of $15.00 on May 11, 2026, which is a significant premium to the current market price of $11.90 and above the 52-week high. This substantial investment by a director-affiliated institutional group immediately post-IPO signals strong conviction in the company's future.